In this issue
- Optimizing TURBT and Optical Diagnostics in Bladder Cancer
- Immuno-Oncology: The Urologist's Role
- Phase 3 Study of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-Sensitive Prostate Cancer: The ARCHES Trial
{optin-asset[id:31,label:Download PDF,linkClass:button download]}